This article is an excerpt from “Here Are Barron’s 10 Leading Stocks for the New Year,” published on Dec. 16, 2023. To see the total record, simply click here.
Medtronic
(ticker: MDT) is a dividend aristocrat, with 45 straight a long time of payout raises. But shares in the business, a prime maker of medical devices, haven’t been regal performers. Its stock, at close to $78, is off 24% in 2022 and is in the pink in excess of the previous 5 many years.
This article is an excerpt from “Here Are Barron’s 10 Leading Stocks for the New Year,” published on Dec. 16, 2023. To see the total record, simply click here.
Medtronic
(ticker: MDT) is a dividend aristocrat, with 45 straight a long time of payout raises. But shares in the business, a prime maker of medical devices, haven’t been regal performers. Its stock, at close to $78, is off 24% in 2022 and is in the pink in excess of the previous 5 many years.
:focal(0x0:3500x2333)/static.texastribune.org/media/files/05417cd32d19e75f1e9c7272aa8c1264/Robert%20Roberson%20IPL%20TT%2029.jpg "Ken Paxton moves to block Robert Roberson’s House testimony")